EMD+Millipore+Corporation
11 Results
Erweiterte Suche
Suchergebnisse
Produkte (0)
Dokumente (0)
Seiten (11)
-
-
Event | 14th Annual PDA Global Conference on Pharmaceutical Microbiology | Merck
Your Partner in QC Microbiology - Speak to our experts about complete pharmaceutical microbiology testing solutions at the PDA Pharmaceutical Microbiology conference. See what's next at Merck -
Event | Immunology 2018 | Merck
Visit us in Booth #835 - Discover unparalleled fluorescence sensitivity and flexibility in a compact, affordable system. With patented Amnis® optics technology inside, the CellStream™ systems are fully-configurable, from 1 to 7 lasers, and are easy-to-upgrade in the lab, allowing researchers to customize according to experimental needs and budget. -
Pressemitteilung: Merck KGaA vereinbart Übernahme von Sigma-Aldrich
Merck KGaA, Darmstadt Germany, announces that they have entered into a definitive agreement under which Merck KGaA, will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry. -
Press Release: Merck Receives 2012 REBRAND™ 100 Global Award
Merck has been named one of the world's most effective rebrands in the 8th annual 2012 REBRAND™ 100 Global awards. -
Press Release: Merck Introduces Bottled Water with Certified Water Quality
Merck, today announced the introduction of two types of bottled water with certified water quality: Water for Cell Culture and Water for Molecular Biology. -
Press Release: Vincent Donovan to Lead BioPharmaceutical Process Solutions at Merck
Merck, today announced that Vincent Donovan has been appointed Head of BioPharmaceutical Process Solutions at Merck. He will assume leadership effective July 1, 2012 and be based at the company's Bedford, Massachusetts office. -
Press Release: Andrew Bulpin to Assume Leadership of Process Solutions at Merck
Merck, today announced that Andrew Bulpin, Head of Global Pharmaceutical Chemicals Solutions Sales at Merck has been appointed Head of the company's Process Solutions Business Unit. -
Press Release: Merck Announces Clinical Research, Licensing and Joint Development Agreement with Sysmex Corporation
Merck, today announced a clinical research, licensing and joint development agreement with Sysmex Corporation of Japan. -
Event | ASCB | EMBO 2018 Annual Meeting | Merck
The combined legacy of renowned Millipore membranes and filtration devices with Sigma-Aldrich media, buffers and reagents means Merck is better positioned than ever to meet-and exceed-the demands of your fast-moving research.